Exposing drug industry funding of UK patient organisations

Piotr Ozieranski, Emily Richard, Shai Mulinari

Research output: Contribution to journalArticlepeer-review

25 Citations (SciVal)
82 Downloads (Pure)

Abstract

From 2012 to 2016 the drug industry donated over £57m (€65m; $73m) to UK patient organisations, with the annual sum more than doubling over the period. The funding benefited a small number of organisations and activities related to research and public involvement. The industry gave priority to commercially high profile conditions. Industry payment disclosures had limited transparency
Original languageEnglish
Article numberl1806
JournalBMJ: British Medical Journal
Volume365
DOIs
Publication statusPublished - 2019 May 23

Subject classification (UKÄ)

  • Health Care Service and Management, Health Policy and Services and Health Economy
  • Sociology (excluding Social Work, Social Psychology and Social Anthropology)

Fingerprint

Dive into the research topics of 'Exposing drug industry funding of UK patient organisations'. Together they form a unique fingerprint.

Cite this